AI assistant
Sending…
ENDRA Life Sciences Inc. — Director's Dealing 2022
May 19, 2022
35444_dirs_2022-05-19_65432687-72da-4604-acf3-ca097720b288.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2022-05-17
Reporting Person: Michelon Francois Roger (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-17 | Common Stock | P | 5100 | $0.19 | Acquired | 97191 | Direct |
More from ENDRA Life Sciences Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23